Evidence map›Paper›PMID 39656817›Full record

ArticleEndocrinology2024

Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma.

Sarah Feely, Nathan Mullen, Padraig T Donlon, Eileen Reidy, Ritihaas Surya Challapalli, Mariam Hassany, Anna Sorushanova, Eduardo Ribes Martinez, Peter Owens, Anne Marie Quinn and 7 more

Abstract read
In one paragraph

Article in Endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sarah FeelyDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.ORCID 0000-0002-8935-2082
Nathan MullenDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.ORCID 0000-0002-7266-2965
Padraig T DonlonDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Eileen ReidyDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Ritihaas Surya ChallapalliDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Mariam HassanyDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Anna SorushanovaDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Eduardo Ribes MartinezDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Peter OwensCentre for Microscopy and Imaging, Anatomy, School of Medicine, University of Galway, Galway, H91 TK33, Ireland.
Anne Marie QuinnDepartment of Anatomic Pathology, Galway University Hospital, Galway, H91 YR71, Ireland.
Abhay PanditScience Foundation Ireland (SFI) Research Centre for Research in Medical Devices (CURAM), Biomedical Science Building, University of Galway, Galway, H91 TK33, Ireland.
Brendan HarhenBiological Mass Spectrometry Core Facility, University of Galway, Galway, H91 TK33, Ireland.
David P FinnDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.
Constanze HantelDepartment of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zurich, Switzerland.
Martin O'HalloranScience Foundation Ireland (SFI) Research Centre for Research in Medical Devices (CURAM), Biomedical Science Building, University of Galway, Galway, H91 TK33, Ireland.
Punit PrakashDepartment of Electrical and Computer Engineering, Kansas State University, Manhattan, KS 66506, USA.
Michael C DennedyDiscipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, H91 V4AY, Ireland.ORCID 0000-0001-9325-6520

Funding

Treating Primary aldosteronism-induced hypertension via microwave thermal therapyR01EB028848 · NIBIB · KANSAS STATE UNIVERSITY · PI PRAKASH, PUNIT · 2020 to 2023
$1.3M
NIBIB NIH HHS R01 EB028848NIH HHS R01EB028848Science Foundation Ireland 20/US/3676Swiss 3R Competence Centre
6 · The paper itself

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex that is associated with a poor prognosis. Developing effective treatment options for ACC is challenging owing to the current lack of representative preclinical models. This study addressed this limitation by developing and characterizing 3-dimensional (3D) cell cultures incorporating the ACC cell lines, MUC-1, HAC15, and H295R in a type I collagen matrix. ACC tissue samples were analyzed by immunohistochemistry to determine the presence of type I collagen in the tumor microenvironment. Cell viability and proliferation were assessed using flow cytometry and confocal microscopy. mRNA expression of steroidogenic enzymes and steroid secretion was analyzed by comparing the 3D and monolayer cell culture models. All cells were successfully cultured in a type I collagen matrix, which is highly expressed in the ACC tumor microenvironment and showed optimal viability until day 7. All 3 models showed increased metabolic and proliferative activity over time. Three-dimensional cell cultures were steroidogenic and demonstrated increased resistance to the gold standard chemotherapy, mitotane, compared with monolayer. The use of these models may lead to an improved understanding of disease pathology and provide a better representative platform for testing and screening of potential therapies.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaCell Culture Techniques, Three DimensionalCell ProliferationCell SurvivalCell Culture TechniquesCell Line, TumorCollagen Type IHumansMitotaneTumor MicroenvironmentCollagen Type IMitotane3D cell culture modelsadrenocortical carcinomadrug resistancepreclinical models

Identifiers

PMID39656817
PMCPMC11650001

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.